Phase 1 Dosing Study of BAX 513 in Healthy Volunteers
This study has been completed.
Sponsor:
Baxalta US Inc.
Information provided by:
Baxalta US Inc.
ClinicalTrials.gov Identifier:
NCT01063101
First received: February 4, 2010
Last updated: June 26, 2015
Last verified: August 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | August 2010 |
| Primary Completion Date: | July 2010 (Final data collection date for primary outcome measure) |